Repressive effect of the phytoestrogen genistein on estradiol-induced uterine leiomyoma cell proliferation

References

• Wilcox L S, Koonin L M, Pokras R, Strauss L T, Xia Z, Peterson H B. Hysterectomy in the United States,1988–1990. Obstet Gynecol 1994; 83: 549–555
   PubMed Web of Science ®Google Scholar
• Lepine L A, Hillis S D, Marchbanks P A, Koonin L M, Morrow B, Kieke B A, Wilcox L S. Hysterectomy surveillance – United States,1980–1993. MMWR CDC Surveill Summ 1997; 46: 1–15
   PubMedGoogle Scholar
• Walker C L, Stewart E A. Uterine fibroids: the elephant in the room. Science 2005; 308: 1589–1592
   PubMed Web of Science ®Google Scholar
• Rein M S. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect 2000; 108(5 Suppl)791–793
   PubMedGoogle Scholar
• Flake G P, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003; 111: 1037–1054
   PubMed Web of Science ®Google Scholar
• Heim M, Frank O, Kampmann G, Sochocky N, Pennimpede T, Fuchs P, Hunziker W, Weber P, Martin I, Bendik I. The phytoestrogen genistein enhances osteogenesis and represses adeipogenic differentiation of human primary bone marrow stromal cells. Endocrinology 2004; 145: 848–859
   PubMed Web of Science ®Google Scholar
• Konstantakopoulos N, Montgomery K G, Chamberlain N, Quinn M A, Baker M S, Rice G E, Georgiou H M, Campbell I G. Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells. Mol Carcinog 2006; 45: 752–763
   PubMed Web of Science ®Google Scholar
• Moore A B, Castro L, Yu L, Zheng X, Di X, Sifre M I, Kissling G E, Newbold R R, Bortner C D, Dixon D. Stimulatory and inhibitory effects of genistein on human uterine leiomyoma cell proliferation are influenced by the concentration. Hum Reprod 2007; 22: 2623–2631
   PubMed Web of Science ®Google Scholar
• Nagata C, Takatsuka N, Kawakami N, Shimizu H. Soy product intake and premenopausal hysterectomy in a follow-up study of Japanese women. Eur J Clin Nutr 2001; 55: 773–777
   PubMed Web of Science ®Google Scholar
• Everitt J I, Wolf D C, Howe S R, Goldsworthy T L, Walker C. Rodent model of reproductive tract leiomyomata. Clinical and pathological features. Am J Pathol 1995; 146: 1556–1567
   PubMed Web of Science ®Google Scholar
• Walker C L, Hunter D, Everitt J I. Uterine leiomyoma in the Eker rat: a unique model for important diseases of women. Genes Chromosomes Cancer 2003; 38: 349–356
   PubMed Web of Science ®Google Scholar
• Howe S R, Gottardis M M, Everitt J I, Golesworthy T L, Wolf D C, Walker C. Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. Am J Pathol 1995; 146: 1568–1579
   PubMed Web of Science ®Google Scholar
• Severino M F, Murray M J, Brandon D D, Clinton G M, Burry K A, Novy M J. Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures. Mol Hum Reprod 1996; 2: 823–828
   PubMed Web of Science ®Google Scholar
• Houston K D, Copland J A, Broaddus R R, Gottardis M M, Fischer S M, Walker C L. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferators – activated receptor γ ligands in uterine leiomyoma. Cancer Res 2003; 63: 1221–1227
   PubMed Web of Science ®Google Scholar
• Shushan A, Ben-Bassat H, Mishni E, Laufer N, Klein B Y, Rojansky N. Inhibition of leiomyoma cell proliferation in vitro by genistein and the protein tyrosine kenase inhibitor TKS050. Fertil Steril 2007; 87: 127–135
   PubMed Web of Science ®Google Scholar
• Gossner G, Choi M, Tan L, et al. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol Oncol 2007; 105: 23–30
   PubMed Web of Science ®Google Scholar
• Huang X, Chen S, Xu L, et al. Genistein inhibits p38 map kinase activation, matrix metalloproteinase type2, and cell invasion in human prostate epithelial cells. Cancer Res 2005; 65: 3470–3478
   PubMed Web of Science ®Google Scholar
• Katdare M, Osborne M, Telang N T. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells. Int J Oncol 2002; 21: 809–815
   PubMed Web of Science ®Google Scholar
• Dang Z C, Audinot V, Papapoulos S E, Boutin J A, Lowik C WGM. Peroxisome proliferator-activated receptor γ (PPARγ) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 2003; 278: 962–967
   PubMed Web of Science ®Google Scholar
• Setchell K D. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998; 68(6 Suppl)1333S–1346S
   PubMed Web of Science ®Google Scholar
• Izumi T, Piskula M K, Osawa S, Obata A, Tobe K, Saito M, Kataoka S, Kubota Y, Kikuchi M. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr 2000; 130: 1695–1699
   PubMed Web of Science ®Google Scholar
• Sharma A M, Staels B. Review: peroxisome proliferator-activated receptor γ and adipose tissue – understanding obesity-related changes in the regulation of lipid and glucose metabolism. J Clin Endocrinol Metab 2007; 92: 386–395
   PubMed Web of Science ®Google Scholar
• Wright H M, Clish C B, Mikami T, Hauser S, Yanagi K, Hiramatsu R, Serhan C N, Spiegelman B M. A synthetic antagonist for the peroxisome proliferator-activated receptor γ inhibits adipocyte differentiation. J Biol Chem 2000; 275: 1873–1877
   PubMed Web of Science ®Google Scholar
• Takeda T, Sakata M, Isobe A, Miyake A, Nishimoto F, Ota Y, Kamiura S, Kimura T. Relationship between metabolic syndrome and uterine leiomyomata: a case-control study. Gynecol Obstet Invest 2008; 66: 14–17
   PubMed Web of Science ®Google Scholar
• Banerjee S, Li Y, Wang Z, Sarkar F H. Multi-targeted therapy of cancer by genistein. Cancer Lett 2008; 269: 226–242
   PubMed Web of Science ®Google Scholar